Randall Kenneth Edward 4/A
4/A · TC BioPharm (Holdings) plc · Filed Jan 11, 2023
Insider Transaction Report
Form 4/AAmended
Randall Kenneth Edward
10% Owner
Transactions
- Purchase
Series B Warrants
2022-11-30+70,000→ 70,000 total(indirect: By Renaissance Capital Partners Ltd)Exercise: $5.00From: 2022-11-30Exp: 2025-05-30→ Ordinary Shares (70,000 underlying) - Purchase
Ordinary Shares [ADS]
2022-11-30$5.00/sh+70,000$350,000→ 136,834 total(indirect: By Renaissance Capital Partners Ltd) - Purchase
Series A Warrants
2022-11-30+70,000→ 70,000 total(indirect: By Renaissance Capital Partners Ltd)Exercise: $5.00From: 2022-11-30Exp: 2028-05-30→ Ordinary Shares (70,000 underlying)
Holdings
- 2,008
Ordinary Shares [ADS]
- 106,129(indirect: By Renaissance Capital Partners Ltd)
Warrants
Exercise: $4.25From: 2022-04-11Exp: 2028-02-10→ Ordinary Shares (106,129 underlying)
Footnotes (2)
- [F1]Series A Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.
- [F2]Series B Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.